Activated Prothrombin Complex Concentrate-Induced Atypical Hemolytic Uremic Syndrome Treated with Eculizumab

08 March 2021 : Case report USA

Challenging differential diagnosis, Unusual or unexpected effect of treatment, Unexpected drug reaction

Hsin Hsiang Clarence Tsai^1CDEF*, Justin Tyler Moyers^2BCDE, Christie J. Moore^3BE, MieMie Thinn^4DE

DOI: 10.12659/AJCR.929616

Am J Case Rep 2021; 22:e929616

Background Case Report Discussion Conclusions References:

Related articles Order reprints Share article Share by email

View HTML version

Figure 2. Proposed mechanism of Factor Eight Inhibitor Bypassing Activity (FEIBA)-induced Atypical Hemolytic Uremic Syndrome (aHUS).

Back to the Article